News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Jul 06, 2020, 22:26 ET U.S. FDA Approves Qwo™ (collagenase clostridium histolyticum-aaes), the First Injectable Treatment for Cellulite
Endo International plc (NASDAQ: ENDP) today announced that it received U.S. Food and Drug Administration (FDA) approval of Qwo™ (collagenase...
Jun 17, 2020, 07:30 ET New Harris Poll Survey Shows 60% of Women Surveyed Feel It's Their Fault They Have Cellulite
Sixty percent (60%) of women surveyed feel it's their fault they have cellulite and 57% feel judged for their cellulite,i according to new Harris...
Jun 16, 2020, 17:00 ET Endo to Announce Second-Quarter 2020 Financial Results
Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2020 financial results on August 6, 2020 and members of its senior management...
Jun 15, 2020, 07:30 ET Endo International plc Announces Final Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations
More Than 97% Of Notes Sought Were Tendered And Accepted Thereby Extending More Than $2.7 Billion Of Endo International plc's Near-Term Debt...
May 29, 2020, 08:00 ET Endo International plc Announces Early Tender Results Of Its Previously Announced Exchange Offers And Consent Solicitations
Endo International plc (the "Company") (NASDAQ: ENDP) announced today the early tender results of the previously announced Exchange Offers and...
May 14, 2020, 17:00 ET Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2020 RBC Capital Markets...
May 14, 2020, 07:38 ET Endo International plc Announces Proposed Exchange Offers And Consent Solicitations
Endo International plc (the "Company") (NASDAQ:ENDP) announced today that its wholly owned subsidiaries, Par Pharmaceutical, Inc., a New York...
May 07, 2020, 06:00 ET Endo Reports First-Quarter 2020 Financial Results and Provides Update Relating to COVID-19 Pandemic
Endo International plc (NASDAQ: ENDP) today reported financial results for the first quarter ended March 31, 2020 and provided an update relating to...
Apr 16, 2020, 17:00 ET Endo to Announce First Quarter 2020 Financial Results
Endo International plc (NASDAQ: ENDP) will announce its first–quarter 2020 financial results on May 7, 2020 and members of its senior management team ...
Feb 19, 2020, 16:20 ET Endo Names Blaise Coleman President and Chief Executive Officer
Endo International plc (NASDAQ: ENDP) today announced that Blaise Coleman, who has served as the Company's Executive Vice President and Chief...
Feb 19, 2020, 16:20 ET Endo Appoints Mark G. Barberio to Board of Directors
Endo International plc (NASDAQ: ENDP) today announced that its Board of Directors has appointed Mark G. Barberio to serve as a director, effective...
Jan 27, 2020, 16:20 ET Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States
Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized ...
Jan 24, 2020, 17:00 ET Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2019 financial results on February 26, 2020 and members of its...
Jan 10, 2020, 11:50 ET Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million
Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Par Pharmaceutical, Inc. (collectively, the ...
Dec 17, 2019, 17:00 ET Endo to Participate at J.P. Morgan Healthcare Conference
Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference in San...
Dec 10, 2019, 08:06 ET Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States
Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has received approval for and...
Nov 22, 2019, 17:00 ET Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference
Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill...
Nov 19, 2019, 16:10 ET Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite
Endo International plc (NASDAQ: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the original Biologics ...
Nov 04, 2019, 16:15 ET Endo Reports Third-Quarter 2019 Financial Results
Endo International plc (NASDAQ: ENDP) today reported third-quarter 2019 financial results, including: Revenues of $729 million decreased 2% compared...
Nov 04, 2019, 16:15 ET Endo Implements CEO Succession Plan
Endo International plc (NASDAQ: ENDP) today announced that Paul V. Campanelli, President and Chief Executive Officer has notified the Board of...
Oct 28, 2019, 07:30 ET Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry" campaign at the Annual Meeting of...
Oct 25, 2019, 07:30 ET Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)
Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of...
Oct 24, 2019, 07:30 ET Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting
Endo International plc (NASDAQ: ENDP) today announced that it will present data on the use of a standing MRI as compared to prone MRI for the...
Oct 02, 2019, 17:00 ET Endo to Announce Third-Quarter 2019 Financial Results
Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2019 financial results on November 5, 2019 and members of its senior management ...
